Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$9.99 - $18.71 $6,893 - $12,909
-690 Reduced 2.23%
30,187 $559,000
Q2 2023

Aug 14, 2023

SELL
$9.17 - $19.29 $98,513 - $207,232
-10,743 Reduced 25.81%
30,877 $341,000
Q1 2023

May 15, 2023

BUY
$12.53 - $21.71 $103,598 - $179,498
8,268 Added 24.79%
41,620 $558,000
Q4 2022

Feb 14, 2023

BUY
$11.61 - $16.11 $93,123 - $129,218
8,021 Added 31.66%
33,352 $412,000
Q3 2022

Nov 14, 2022

SELL
$12.21 - $19.7 $15,506 - $25,019
-1,270 Reduced 4.77%
25,331 $353,000
Q2 2022

Aug 15, 2022

SELL
$11.23 - $19.59 $74,106 - $129,274
-6,599 Reduced 19.88%
26,601 $367,000
Q4 2021

Feb 11, 2022

SELL
$14.28 - $19.53 $24,276 - $33,201
-1,700 Reduced 4.87%
33,200 $541,000
Q1 2021

May 17, 2021

SELL
$19.33 - $37.75 $40,593 - $79,275
-2,100 Reduced 5.68%
34,900 $805,000
Q4 2020

Feb 03, 2021

SELL
$24.48 - $42.47 $112,608 - $195,362
-4,600 Reduced 11.06%
37,000 $914,000
Q3 2020

Nov 16, 2020

SELL
$39.09 - $53.44 $46,908 - $64,128
-1,200 Reduced 2.8%
41,600 $1.73 Million
Q2 2020

Aug 12, 2020

BUY
$46.7 - $92.04 $186,800 - $368,160
4,000 Added 10.31%
42,800 $2.05 Million
Q1 2020

May 06, 2020

BUY
$48.35 - $118.68 $87,030 - $213,624
1,800 Added 4.86%
38,800 $2.44 Million
Q3 2019

Nov 12, 2019

BUY
$58.69 - $80.46 $305,188 - $418,391
5,200 Added 16.35%
37,000 $2.46 Million
Q2 2019

Aug 14, 2019

BUY
$77.77 - $120.68 $124,432 - $193,088
1,600 Added 5.3%
31,800 $2.53 Million
Q1 2019

May 13, 2019

BUY
$91.83 - $120.68 $716,274 - $941,304
7,800 Added 34.82%
30,200 $3.38 Million
Q4 2018

Feb 11, 2019

SELL
$85.79 - $126.46 $25,737 - $37,938
-300 Reduced 1.32%
22,400 $2.26 Million
Q2 2018

Aug 03, 2018

BUY
$60.0 - $85.67 $666,660 - $951,879
11,111 Added 95.88%
22,700 $1.91 Million
Q1 2018

May 07, 2018

SELL
$52.72 - $67.25 $5,272 - $6,725
-100 Reduced 0.86%
11,589 $713,000
Q4 2017

Feb 08, 2018

BUY
$58.2 - $72.76 $468,335 - $585,499
8,047 Added 220.95%
11,689 $683,000
Q3 2017

Nov 01, 2017

BUY
$57.01 - $118.75 $207,630 - $432,487
3,642
3,642 $211,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.